ABIOMED NASDAQ:ABMD is reporting this earnings, what to expect.
ABIOMED NASDAQ:ABMD headquartered in Danvers, Massachusetts, United States is reporting their earnings on 05/02/2018 before the bell. Street forecast for the quarter ending March 2018 is $0.64.
According to stock market daily analyst this is Lower then same time previous year. ABIOMED reported EPS for the same quarter last year was $0.64.
Overview of ABIOMED NASDAQ:ABMD
Abiomed (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
|% Change from 52 Week Low|
|% Change from 52 Week High|